Akums Drugs & Pharmaceuticals Ltd., India’s leading contract development and manufacturing organization (CDMO), has entered a strategic in-licensing agreement with Caregen Co., Ltd., a globally recognized biotechnology leader based in South Korea.

This collaboration represents a significant step in introducing a range of advanced specialty products to the Indian market, including nutraceuticals, pharmaceuticals, and differentiated topical and injectable cosmeceuticals. The offerings, which feature innovative Skinceuticals and Hairceuticals, are designed to cater to the evolving needs of Indian consumers, with a focus on health, beauty, and wellness.

The partnership combines Caregen’s expertise in peptides, growth factors, and advanced formulations with Akums’ robust manufacturing capabilities and widespread market reach. Together, the two companies aim to deliver innovative, science-backed solutions that align with the increasing consumer demand for wellness-oriented products in India.

Through this collaboration, the Indian market will gain access to cutting-edge products such as topical treatments for skin and hair care, injectable solutions for deeper rejuvenation and repair, and premium nutraceuticals that support holistic well-being. These offerings are tailored to India’s diverse demographics, unique climatic conditions, and varied lifestyles, ensuring they resonate with local consumers.

India’s cosmeceutical and nutraceutical sectors are experiencing rapid growth as awareness around health and wellness continues to rise. By leveraging Akums’ manufacturing capabilities and Caregen’s proprietary peptide-based technologies, the partnership positions itself as a leader in addressing the dynamic needs of these burgeoning markets.

Sanjeev Jain, Managing Director of Akums, expressed enthusiasm for the partnership, emphasizing its potential to redefine healthcare and beauty in India. He highlighted Akums’ commitment to delivering innovative and impactful products that empower individuals to look and feel their best.

Similarly, Dr. Chung Yong-Ji, CEO of Caregen, underscored the immense potential of the Indian market, describing it as vibrant and dynamic. He emphasized that integrating pharmaceutical solutions with nutraceutical and cosmeceutical innovations would significantly enhance the value offered to consumers.

Sandeep Jain, Co-Managing Director of Akums, reiterated the company’s mission to make world-class products accessible to the Indian market. He noted that Akums’ manufacturing expertise would ensure the seamless delivery of these innovative offerings, further solidifying the company’s position as a pioneer in healthcare and beauty solutions.

This collaboration aligns closely with India’s ‘Make in India’ vision by committing to the local manufacturing of global-standard products. In doing so, it not only supports economic growth and reduces reliance on imports but also reaffirms India’s position as a hub for innovation in healthcare and beauty.

By combining global expertise with local insight, Akums and Caregen are poised to revolutionize India’s cosmeceutical and nutraceutical industries, offering customized solutions that reflect the unique needs of Indian consumers. This partnership marks a pivotal moment in the nation’s wellness journey, setting new benchmarks in healthcare and beauty innovation.